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INTRODUCTION
While the ovary, testes, and adrenal gland generate neuroac-
tive steroids that impact brain function, the central nervous
system (CNS) itself generates smaller levels of steroids (neuros-
teroids) de novo from cholesterol (Corpechot et al., 1983). The
enzymes responsible for steroid synthesis localize to speciﬁc cell
types within the CNS, including the two mitochondrial pro-
teins that initiate steroidogenesis, cytochrome P450 side-chain
cleavage (P450scc), and the steroidogenic acute regulatory pro-
tein (StAR/STARD1; Compagnone and Mellon, 2000; King et al.,
2002).
Steroid hormone production begins with the conversion of
cholesterol to pregnenolone by P450scc on the matrix side of the
inner mitochondrial membrane (Bhangoo et al., 2006). Depend-
ing on the cell type, pregnenolone is further metabolized to other
steroids, such as progesterone, allopregnanolone, and estrogen.
The rate at which P450scc generates the steroid is determined by
its access to cholesterol substrate. This access is controlled by StAR,
which catalyzes the delivery of cholesterol from the outer mito-
chondrial membrane to the inner and P450scc (Figure 1; Clark et
al., 1994).
Surprisingly, StAR elicits this intermembrane transfer from
outside the mitochondria, prior to its import into the organelle,
and processing to its mature 30-kDa forms (reviewed in Bhangoo
et al., 2006). This makes its difﬁcult-to-detect 37-kDa “precursor”
the active form of StAR, solely due to its positioning outside the
mitochondria. Import ends StAR activity. Thus, ongoing steroid
synthesis requires ongoing synthesis of StAR.
In summary, the capability and capacity of a cell tomake steroid
is identiﬁed by the presence of P450scc. The rate and level of
steroid production is marked by the expression level of StAR. Loss
of either protein causes a catastrophic loss of circulating steroids
(Hasegawa et al., 2000; Hu et al., 2002). While most research on
StAR relates to its role in classic endocrine tissues in the gonads
and adrenal gland, recent attention has turned to its importance
in neurosteroid production in the CNS.
EXPRESSION OF StAR IN THE ADULT AND DEVELOPING CNS
The presence of StAR mRNA and protein in the CNS was ﬁrst
unambiguously demonstrated by Furukawa et al. (1998) and King
et al. (2002) respectively. Subsequent research demonstrated the
conservation of its presence in the brain evolutionarily, such as in
the songbird and the eel (Li et al., 2003; London et al., 2006; Lon-
don and Schlinger, 2007). Other data provide conﬂicting data for
the expression and extent of expression of StAR in the ﬁsh brain
and evidence for very low expression in the CNS of the stingray
(Bauer et al., 2000; Kusakabe et al., 2002; von Hofsten et al., 2002;
Nunez et al., 2005; Nunez and Evans, 2007).
Like P450scc and the enzyme that converts pregnenolone to
progesterone, 3β-hydroxysteroid dehydrogenase (3β-HSD), the
level of StAR in the brain is much lower than in endocrine tis-
sues – approximately 0.1–1% of that found in the adrenal (Guen-
noun et al., 1995; Furukawa et al., 1998). However, StAR itself
is expressed at a level much lower than 3β-HSD, but at least an
order of magnitude greater than P450scc in the rat CNS (Mellon
and Deschepper, 1993; Guennoun et al., 1995; Sanne and Krueger,
1995; Furukawa et al., 1998). Still, local concentrations of neuros-
teroids produced by neural cells can be far greater than that in
serum.
Consistent with its critical role in steroidogenesis, StAR
co-localizes with P450scc in the CNS (King et al., 2002).
Steroidogenic regions marked by StAR and P450scc include
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FIGURE 1 | Mechanism of StAR action. Following synthesis and an
activating phosphorylation (Pi ), StAR catalyzes the movement of cholesterol
(Ch) in the outer mitochondrial membrane to the inner membrane through
an unknown mechanism. There, cytochrome P450scc converts cholesterol
to the steroid pregnenolone (P5), using reducing equivalents supplied by
adrenodoxin reductase via adrenodoxin (not depicted). StAR is then
imported into the mitochondria and processed to smaller forms.
the cortex, hippocampus, hypothalamus, cerebellum, and cranial
nerve motoneurons (Compagnone et al., 1995; King et al., 2002;
Sierra et al., 2003); summarized in (Do Rego et al., 2009). As with
P450scc, StAR is expressed in speciﬁc neuronal and astrocyte pop-
ulations. The two proteins co-localize to individual neuronal and
glial cell types within the neonatal and adult brain (Mellon and
Deschepper, 1993; Furukawa et al., 1998; King et al., 2002, 2004a).
Speciﬁc cell types in the retina and Schwann cells synthesize both
StAR and P450scc and hence, neurosteroids (Jung-Testas et al.,
1989; Guarneri et al., 1994; Compagnone et al., 1995; Koenig et al.,
1995; Patte-Mensah et al., 2003; Provost et al., 2003; Benmessahel
et al., 2004).
The ability of the brain to synthesize neurosteroids is acquired
early in development (Compagnone et al., 1995; Pezzi et al., 2003;
King et al., 2004a). Embryogenesis marks the time of greatest
neuronal growth and development as well as the peak of neu-
rosteroid production. The developing CNS also expresses StAR in
dividing cells and germinal layers (Sierra et al., 2003). Neona-
tal peaks in StAR, P450scc, and aromatase mRNA in Purkinje
cells and other cerebellar neurons reﬂect high levels of de novo
synthesis of progesterone and estradiol, which can regulate den-
dritic growth, spine, generation, and synaptogenesis (Sakamoto
et al., 2003; Lavaque et al., 2006; Tsutsui, 2006). Developmental
expression of StAR is also found in the zebra ﬁnch (London and
Schlinger, 2007).
REGULATION OF StAR EXPRESSION
In endocrine tissues, trophic hormones like LH and ACTH con-
trol StAR expression and hence, steroid production. The identities
of similar factors that regulate StAR in the CNS remain largely
unknown.
In human SH-SY5Y neuroblastoma cells, gonadotropin-
releasing hormone (GnRH) triples StAR and P450scc levels within
90min via upregulation of LH (Rosati et al., 2011). As in gonadal
tissues, levels of StAR in differentiated rat primary hippocam-
pal neurons and human M17 neuroblastoma cells also respond
to LH within 30min (Liu et al., 2007). Whether these hormones
inﬂuence StAR in vivo remains unclear, although LH and GnRH
receptors have been identiﬁed, for instance, in hippocampal neu-
rons (Lei et al., 1993; Webber et al., 2006; Wilson et al., 2006; Liu
et al., 2007). Recent in vitro and in vivo studies also implicate
a resident lipid, palmitoylethanolamide (PEA). PEA upregulates
StAR and P450scc in the rat brain, rat C6 glioma cells, and murine
astrocytes (Sasso et al., 2010; Raso et al., 2011).
The intracellular mechanism that governs StAR expression
in neural tissue has been shown to involve the cAMP second
messenger pathway as previously observed in endocrine tissues.
Stimulation of the cAMP pathway induces StAR expression and
steroidogenesis in neural cells (Papadopoulos and Guarneri, 1994;
Roscetti et al., 1994; Arakane et al., 1997; Mellon et al., 2001;
King et al., 2002; Jo et al., 2005; Lavaque et al., 2006; Manna
et al., 2006; Karri et al., 2007). In one notable but unexplained
exception, StAR mRNA levels decline with cAMP stimulation
in Schwann cells in spite of increased neurosteroid production
(Benmessahel et al., 2004). A preliminary report with an inﬂam-
matory model in mice indicates that StAR levels in the spinal cord
as in testicular Leydig cells are derepressed with downregulation
of COX-2, increasing analgesic neurosteroid production (Wang
et al., 2003; Inceoglu et al., 2008). This effect on StAR may require
increased cAMP.
TRANSCRIPTION FACTORS CONTROLLING StAR
EXPRESSION
The trans-acting factors controlling StAR gene expression in the
CNS remain elusive. The effect of PEA is mediated through its
binding of the peroxisome-proliferator activated receptor (PPAR)-
α (Sasso et al., 2010; Raso et al., 2011). As in ovarian theca cells
andmouse K28 Leydig cells, chronic stimulationwith retinoic acid
increases StAR and steroid production in GI-1 human glia cells
(Kushida and Tamura, 2009; Lavoie and King, 2009). In contrast,
long-term treatment with retinoid X and retinoic acid receptor
ligand 9-cis-retinoic acid has no effect on StAR gene expression in
rat hippocampal slices (Munetsuna et al., 2009b).
Interestingly, steroidogenic factor 1 (SF-1/NR5A1) and DAX-
1 which are critical in StAR gene regulation in endocrine tissues,
appear to bemostly or entirely uninvolved. This is evidenced by the
very limited number of regions expressing these transcription fac-
tors compared to StAR.Both SF-1 andDAX-1 localize to the rodent
ventral medial hypothalamus (VMH; Guo et al., 1995; Ikeda et
al., 1995, 1996; Shinoda et al., 1995b). In one report, SF-1 was
identiﬁed in hippocampal neurons, with expression overlapping
StAR and aromatase (Wehrenberg et al., 2001). Targeted knockout
of the transcription factor disrupts the organization of the ven-
tromedial nucleus (Shinoda et al., 1995a; Ikeda et al., 1996) and
causes increased anxiety-like behavior (Kim et al., 2009). However,
these changes are apparently unrelated to changes in neurosteroid
production (Bhangoo et al., 2006; Kim et al., 2008).
An exciting aspect of neurosteroids is that certain neuros-
teroids such as allopregnanolone exert non-genomic changes pri-
marily through ion channels found in target cells on the order
of seconds to minutes. By implication, neurosteroids should be
synthesized within a similar time frame. However, such rapid
changes in de novo synthesis, while they may exist, have yet to be
demonstrated. Such a change would likely involve translational or
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post-translational regulation of StAR, such as an activating phos-
phorylation of the protein by PKA (Roscetti et al., 1994; Arakane
et al., 1997; Mellon et al., 2001; King et al., 2002; Jo et al., 2005;
Lavaque et al., 2006; Manna et al., 2006). Increases within 5min
in steroid production have been observed in peripheral tissues,
such as adrenocortical cells (DiBartolomeis and Jefcoate, 1984).
It should be noted that other studies, primarily in birds, describe
rapid (on the order of 5–10min) changes in the levels of aro-
matase and 3β-HSD activities that result in modest alterations
in the levels of neurosteroids metabolized from steroids obtained
from peripheral sources (Balthazart et al., 2006; London et al.,
2009).
ROLE OF StAR IN THE BRAIN
The multiplicity of regions expressing StAR and P450scc reﬂects
the roles for a neurosteroids in a variety of CNS functions. By
example, social isolation stress increases StAR expression in the
hippocampus to elevate estrogen levels (Munetsuna et al., 2009a).
Conﬂicting reports exist as to whether ethanol also increases StAR
mRNA in the cortex and hippocampus (Serra et al., 2006; Boyd
et al., 2010). The hypnotic effect of pentobarbital and antinoci-
ceptive activity at the level of the spinal cord are linked to PEA-
stimulated StAR-dependent allopregnanolone production inmice
(Sasso et al., 2010, 2011). Increased production of StAR and neu-
rosteroids in the spinal cord elicited by select anti-inﬂammatory
factors are linked to antihyperalgesia (Inceoglu et al., 2008).
Here, we summarize other studies that speciﬁcally describe the
involvement of StAR.
SEXUAL FUNCTION
Neurosteroids and the proteins responsible for their synthesis like
StAR and P450scc are found in structures relevant for sexual
behavior and reproduction, such as the amygdala,medial preoptic
area, andVMH (Compagnone et al., 1995; King et al., 2002; Sierra
et al., 2003; King, 2008). The importance of neurosteroid produc-
tion in reproduction is exempliﬁed by the ﬁnding that inhibition
of hypothalamic progesterone synthesis blocks the ovulatory LH
surge in female rats (Micevych et al., 2003). The protein is also
found in pituitary gonadotrope LβT2 cells (Lopez de et al., 2007).
StAR may serve a different function than in steroid production in
these cells since they lack P450scc.
Differences in neurosteroids with gender are mirrored by dif-
ferences in StAR.Male rats exhibit higher cerebellar levels of StAR,
P450scc, and aromatase mRNAs and by implication, higher levels
of neurosteroids (Lavaque et al., 2006). The opposite holds true
for StAR in the zebra ﬁnch (Mirzatoni et al., 2010).
NEUROPROTECTION
Neurosteroids can be neuroprotective and their synthesis changes
with aging and injury. Similarly, StAR changes with neuronal
insults. For instance, excitotoxic stimuli like kainic acid and
NMDA stimulate the generation of StAR and neurosteroids in the
hippocampus (Kimoto et al., 2001; Sierra et al., 2003). Damage to
the inferior olive elicited by i.p. injection of 3-acetylpyridine ele-
vates StAR,P450scc, and aromatasemRNA levels in cerebellar neu-
rons (Lavaque et al., 2006). The neuroprotective effects of PEA in
murine astrocytes are linked to StAR-dependent allopregnanolone
production (Raso et al., 2011).
Changes in neuroprotection and spinal density in hippocampal
neurons correlate with StAR-dependent production of estrogen.
Knockdown of StAR expression in these neurons reduces estradiol
synthesis, increases cell death, reduces proliferation and causes
alterations in spine densities, synaptic protein levels, and axon
outgrowth in vitro (Fester et al., 2006; Prange-Kiel and Rune,
2006; Prange-Kiel et al., 2006; von Schassen et al., 2006). Given
that GnRH can induce hippocampal estradiol synthesis, changes
in spine density observed with the ovarian cycle may depend
on changes in release of this hormone with the cycle within the
hippocampus (Prange-Kiel et al., 2008, 2009).
Aging also increases StAR levels in the rat brain (Sierra et al.,
2003). These changes may compose a neuroprotective response,
mediated by neurons and astrocytes. Neurodegenerative diseases
further evoke StAR expression. Levels of StAR rise in Alzheimer
disease, notably in hippocampal pyramidal neurons that express
LH receptors (Webber et al., 2006). This rise correlates with a sim-
ilar increase in LH. In Niemann-Pick disease type C model mice,
compromised expression of StAR and consequently, neuroprotec-
tive estradiol by affected cortical astrocytes relate to progression
of the disease (Chen et al., 2007).
StAR-INDEPENDENT STEROIDOGENESIS
It is important to mention that StAR-independent pathways of
intramitochondrial cholesterol transfer do exist, as exempliﬁed in
the human placenta, the only steroidogenic tissue known to not
express StAR (Bhangoo et al., 2006). These pathways also reside
in StAR-positive cell types, but generate fractional amounts of
steroid compared to StAR. These pathways are largely uncharac-
terized, but contribute to basal steroid production and appear to
be unregulated.
Unlike hydrophobic cholesterol, hydroxylated forms of cho-
lesterol (oxysterols) can freely diffuse between mitochondrial
membranes to P450scc without the assistance of StAR. Oxysterol-
dependent steroid production may be important in testicular
development (Hutson, 2006). In the brain, the predominant
oxysterol, 24S-hydroxycholesterol, could conceivably represent
a source of neurosteroids (Lutjohann et al., 1996; King et al.,
2004b).
A role for the peripheral-type mitochondrial benzodiazepine
receptor/translocator protein (PBR/TSPO) alone or in coordina-
tion with StAR has also been proposed (Papadopoulos, 2004).
Endozepines that bind PBR regulate de novo neurosteroid produc-
tion in C6-2B glioma cells (Papadopoulos et al., 1992). Still, this
ubiquitous protein usually exists in the outermitochondrialmem-
brane as part of the permeability transition pore complex, which
controls mitochondrial integrity (Decaudin, 2004). In fact, PBR
ligands can induce mitochondrial swelling and are pro-apoptotic
(Chelli et al., 2001;Decaudin, 2004). Its knockout is embryonically
lethal, reﬂecting an essential functionbeyond steroidogenesis, such
as in apoptosis which also affects steroid production (Papadopou-
los et al., 1997; King et al., 1998). Correspondingly, knockdown
of PBR impairs mitochondrial protein import perhaps secondar-
ily to loss of the electrochemical potential, also crucial to steroid
synthesis (King and Stocco, 1996; King et al., 1999, 2000; Hauet
et al., 2005). Therefore, while PBR may support carom steroid
production, evidence for a direct role is lacking.
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CONCLUSION
Current research supports the presence of StAR as a measure of
the level of neurosteroid production in the CNS and thus, a tool to
probe the importance and regulationof neurosteroids. Factors that
control StAR expression and activation control neurosteroid syn-
thesis. The speedwithwhich StARand thus,neurosteroid synthesis
occur represents a consideration inmodels of neurosteroid action.
Knockouts of StAR and P450scc should disrupt neurosteroid
production in the brain and ergo, neurosteroid-regulated func-
tions. Patients with mutations in these proteins present deﬁcits
in gonadal and adrenal steroids that manifest as congenital lipoid
adrenal hyperplasia and non-classical familial glucocorticoid deﬁ-
ciency type 3 (Lin et al., 1995; Metherell et al., 2009; reviewed
in King et al., 2011). The presentation of these conditions in
patients and mouse models can include reproductive defects,
hypoglycemia, and salt wasting. However, an increased inci-
dence of cognitive deﬁcits and brain developmental or behavioral
abnormalities separable from the physiologic phenotype has yet
to be established (Bhangoo et al., 2006; Abdulhadi-Atwan et al.,
2007). One possibility is that the brain adjusts to the permanent
loss of neurosteroids during development. As well, changes in sex-
ual behavior and function could bemasked by the overriding effect
of the loss of gonadal sex steroid production.
Still, these ﬁndings question the signiﬁcance of neurosteroids.
More rigorous and sophisticated studies of patients and knock-
out animals are required since many studies using inhibitors
of steroidogenesis point to a vital role for these compounds in
the CNS.
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